Nina Volf mainly assists in filing and prosecution of Italian, European and international patent applications, patentability opinions and freedom to operate (FtO) opinions in the fields of life sciences, biotechnology, and pharmaceuticals. During more than five years of academic research experience she has worked simultaneously on multiple projects in the cardiovascular and oncology fields, contributing in particular to the advances in the field of gene therapy, and specializing for patents in the fields of biotechnology, antibodies, RNA-based therapeutics, and gene therapy.

Nina Volf speaks English, French, Italian and Croatian and has been active in the field of IP since 2022.